Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...
GlobalData on MSN19h
Alleviant Medical secures $90m to launch pivotal aortic stent trialThe $90m will be used to launch the second of two pivotal trials examining the company’s therapy for patients living with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback